BGD x UCB Roundtable

July 7, 2025
Brussels, Belgium

Boosting Innovation and Competitiveness: Strategies for the Biopharmaceutical Sector in Europe

The biopharmaceutical sector is the fifth largest export industry in the European Union. Ensuring its growth and competitiveness is vital for European prosperity, yet geopolitical uncertainty is impacting productivity and increasing costs. Following the publication of the European Union’s first life science strategy in four years, the BGD x UCB Roundtable in Brussels brought together leading voices from business and government to discuss the challenges facing the sector.

Select Participants

Fiona du Monceau
Executive Vice-President
UCB
Nathalie Moll
Director-General
European Federation of Pharmaceutical Industries and Associations
Damien Levie
Head of Unit, Directorate-General Trade and Economic Security
European Commission
Lars-Hendrik Röller
Founder and Chair
Berlin Global Dialogue
Ingmar Schuster
Provolut
Niklas Blomberg
Executive Director
Innovative Health Initiative
Carolin Ven
Chief Executive Ofiicer
Pharma.be

Event Photos

Impressions from our roundtable.

No items found.
We use cookies to ensure that we give you the best experience on our website. By
continuing on this website, you consent to the use of cookies. Please learn more from
our data privacy declaration.